Trump Considers Rescheduling Marijuana to Boost Industry and Tax Revenue

U.S. President Donald Trump is considering an executive order to reclassify marijuana as a Schedule III drug, which could significantly impact the cannabis industry by easing regulations, increasing research opportunities, and improving access to funding. The move would mark a major shift in federal drug policy, potentially lowering taxes and making it easier for banks and investors to participate in the sector. However, no final decision has been made yet, and the DEA will review the recommendation from health authorities.